Peter Bentham

7.1k citations

63 papers · 3.2k indexed · 2 hit papers · h-index 28

Impact in

Psychiatry and Mental health top 1%
- Dementia and Cognitive Impairment Research
- Schizophrenia research and treatment
Biological Psychiatry top 5%

Papers in ⓘ

Research and Theory 3
Psychiatry and Mental health 34
- Dementia and Cognitive Impairment Research 21
- Electroconvulsive Therapy Studies 9
- Schizophrenia research and treatment 5

Co-authors: Peter Crome (3 shared papers)Claude M. Wischik (9 shared papers)C Lendon (2 shared papers)Damon Wischik (3 shared papers)Wendy Hardyman (2 shared papers)Jan R. Oyebode (7 shared papers)Robert K. Hills (3 shared papers)Roger T. Staff (7 shared papers)
Journals: International Journal of Geriatric Psychiatry (5 papers)Alzheimer s & Dementia (4 papers)Journal of Alzheimer s Disease (4 papers)The Lancet (3 papers)Developmental Medicine & Child Neurology (2 papers)
Partner nations: United Kingdom Australia United States

In The Last Decade

Peter Bentham

61 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial 2016 · 321 citations

Peers

Countries citing papers authored by Peter Bentham

Since Specialization

Citations

This map shows the geographic impact of Peter Bentham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bentham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bentham more than expected).

Fields of papers citing papers by Peter Bentham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bentham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bentham. The network helps show where Peter Bentham may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Bentham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Bentham Line = papers co-authored together Peter Bentham links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial The Lancet ·Carol A. Courtney, Dawn Farrell, R. Gray, Robert K. Hills, Launa M. J. Lynch, E. Sellwood, SJ Edwards, Wendy Hardyman, James Raftery, Peter Crome, C Lendon, Helen A. Shaw, Peter Bentham Hit paper breakdown →	2004	612
2	Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial The Lancet ·Serge Gauthier, Howard Feldman, Lon S. Schneider, Gordon Wilcock, Giovanni B. Frisoni, Jiri Hardlund, Hans J. Moebius, Peter Bentham, Karin A. Kook, Damon Wischik, B. Schelter, Charles S. Davis, Roger T. Staff, Luc Bracoud, Kohkan Shamsi, John M. D. Storey, Charles R. Harrington, Claude M. Wischik Hit paper breakdown →	2016	321
3	Determinants of burden in those who care for someone with dementia International Journal of Geriatric Psychiatry ·Paul Campbell, Jacob Wright, Jan R. Oyebode, Dominic Job, Peter Crome, Peter Bentham, Lisa Jones, C Lendon	2008	208
4	Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease Journal of Alzheimer s Disease ·Claude M. Wischik, Roger T. Staff, Damon Wischik, Peter Bentham, Alison D. Murray, John M. D. Storey, Karin A. Kook, Charles R. Harrington	2015	199
5	Donepezil for the Treatment of Agitation in Alzheimer's Disease New England Journal of Medicine ·Robert Howard, Edmund Juszczak, Clive Ballard, Peter Bentham, Richard G. Brown, Roger Bullock, Alistair Burns, Clive Holmes, Robin Jacoby, Tony Johnson, Martín Knapp, James Lindesay, John T. O’Brien, Gordon Wilcock, Cornelius Katona, Roy Jones, Julia DeCesare, Michaela Rodger	2007	192
6	EQ-5D in Patients With Dementia An Investigation of Inter-Rater Agreement Medical Care ·Wendy Coucill, Stirling Bryan, Peter Bentham, Ann E. Buckley, Ann Laight	2001	140
7	Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease JAMA Neurology ·Robert Howard, Olga Zubko, Rosie Bradley, Emma Harper, Lynn Pank, John T. O’Brien, Chris Fox, Naji Tabet, Gill Livingston, Peter Bentham, Rupert McShane, Alistair Burns, Craig Ritchie, Suzanne Reeves, Simon Lovestone, Clive Ballard, Wendy Noble, Ramin Nilforooshan, Gordon Wilcock, Richard Gray, (unknown)	2019	133
8	Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol Cochrane Database of Systematic Reviews ·Ed Day, Peter Bentham, Rhiannon Callaghan, Tarun Kuruvilla, Sanju George	2013	103
9	O3‐04–07: Tau aggregation inhibitor (TAI) therapy with rember^™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks Alzheimer s & Dementia ·Claude M. Wischik, Peter Bentham, Damon Wischik, Kwang Meng Seng	2008	98
10	Semantic memory is impaired in schizophrenia Biological Psychiatry ·AJ McKay, Peter J. McKenna, Peter Bentham, Ann Mortimer, Alison Holbery, John R. Hodges	1996	84
11	Olfactory identification is impaired in clinic‐based patients with vascular dementia and senile dementia of Alzheimer type International Journal of Geriatric Psychiatry ·Alison Gray, Vince Staples, Karen Murren, Avtar Dhariwal, Peter Bentham	2001	83
12	Proxy completion of EQ-5D in patients with dementia Quality of Life Research ·Stirling Bryan, Wendy Hardyman, Peter Bentham, Ann E. Buckley, Ann Laight	2005	74
13	Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse Cochrane Database of Systematic Reviews ·Ed Day, Peter Bentham, Rhiannon Callaghan, T Kuruvilla, Sanju George	2004	69
14	Brief Psychosocial Therapy for the Treatment of Agitation in Alzheimer Disease (The CALM-AD Trial) American Journal of Geriatric Psychiatry ·Clive Ballard, Richard G. Brown, Jane Fossey, Simon Douglas, Paul Bradley, Judith Hancock, Ian James, Edmund Juszczak, Peter Bentham, Alistair Burns, James Lindesay, Robin Jacoby, John T. O’Brien, Roger Bullock, Tony Johnson, Clive Holmes, Robert Howard	2009	62
15	Role of 5HT2A and 5HT2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease Neurobiology of Aging ·Antonia L. Pritchard, Judith Harris, Colin Pritchard, John D. Coates, Sayeed Haque, Roger Holder, Peter Bentham, Corinne Lendon	2006	60
16	Catatonia, autism, and ECT Developmental Medicine & Child Neurology ·Frank K M Zaw, Gordon Bates, Vijaya Murali, Peter Bentham	1999	56
17	Role of Serotonin Transporter Polymorphisms in the Behavioural and Psychological Symptoms in Probable Alzheimer Disease Patients Dementia and Geriatric Cognitive Disorders ·Antonia L. Pritchard, Colin Pritchard, Peter Bentham, Corinne Lendon	2007	52
18	Aspirin in Alzheimer’s Disease Stroke ·Hanneke Thoonsen, Edo Richard, Peter Bentham, Richard Gray, Nan van Geloven, Rob J. de Haan, Willem A. van Gool, Paul J. Nederkoorn	2010	48
19	Silicon-Rich Mineral Water as a Non-Invasive Test of the ‘Aluminum Hypothesis’ in Alzheimer's Disease Journal of Alzheimer s Disease ·Samantha Davenward, Peter Bentham, J. Barry Wright, Peter Crome, Deborah Job, Anthony Polwart, Christopher Exley	2012	47
20	The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease Journal of Neurology Neurosurgery & Psychiatry ·Antonia L. Pritchard, Jessica Harris, Colin Pritchard, John D. Coates, Sayeed Haque, R Holder, Peter Bentham, Corinne Lendon	2006	44

About Peter Bentham

Peter Bentham is a scholar working on Research and Theory, Psychiatry and Mental health, Neurology, Biological Psychiatry and Pharmacology, having authored 63 papers that have together received 3.2k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (21 papers), Alzheimer's disease research and treatments (13 papers), Electroconvulsive Therapy Studies (9 papers), Treatment of Major Depression (7 papers), Geriatric Care and Nursing Homes (7 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Schizophrenia research and treatment (5 papers) and Neurological Disorders and Treatments (5 papers). The work is most often cited by research in Psychiatry and Mental health (1.2k citations), Biological Psychiatry (137 citations), Geriatrics and Gerontology (199 citations), Neurology (380 citations) and Pharmacology (707 citations). Peter Bentham has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Peter Crome, Claude M. Wischik, C Lendon, Damon Wischik, Wendy Hardyman, Jan R. Oyebode, Robert K. Hills, Roger T. Staff, Karin A. Kook and Carol A. Courtney. Their work appears in journals such as International Journal of Geriatric Psychiatry, Alzheimer s & Dementia, Journal of Alzheimer s Disease, The Lancet and Developmental Medicine & Child Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact